{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:16:28Z","timestamp":1792642588180,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":7254,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1046\/j.1538-7836.2003.00096.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:02:18Z","timestamp":1047441738000},"page":"220-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype"],"prefix":"10.1016","volume":"1","author":[{"given":"R.","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"JR","given":"H.H.","family":"Kazazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-9525(88)90156-4","article-title":"The molecular basis of hemophilia A in man","volume":"4","author":"Antonarakis","year":"1988","journal-title":"Trends Genet"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0887-7963(92)70174-6","article-title":"Expression and structure-function properties of recombinant factor VIII","volume":"4","author":"Kaufman","year":"1992","journal-title":"Transfusion Med Rev"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0020","series-title":"Haemostasis and Thrombosis: Basic Principles and Clinical Practice","first-page":"109","article-title":"Coagulation factors V and VIII","author":"Hoyer","year":"1994"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1089\/hum.1997.8.16-1881","article-title":"A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension","volume":"8","author":"Rinsch","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nbt0898-757","article-title":"Regulation of gene expression in vivo following transduction by two separate rAAV vectors","volume":"16","author":"Katherine","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.283.5398.88","article-title":"regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer","volume":"283","author":"Ye","year":"1999","journal-title":"Science"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of hemophilia A","volume":"10","author":"Lawler","year":"1995","journal-title":"Nat Genet"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V60.3.727.727","article-title":"A canine model of hemophilic (factorVIII. C deficiency) bleeding","volume":"60","author":"Giles","year":"1982","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0050","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein. Comparative hemostatic response after infusions into hemophilic and von Willebrand deiease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1073\/pnas.92.4.1023","article-title":"Gene therapy for hemphilia A. Production of therapeutic levels of human factor VIII in vivo in mice","volume":"92","author":"Dwarki","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0060","unstructured":"Greengard JS, Bodner M, McCormack J, Edwards JL, Sensintaffar D, Hsu DePolo NJ, Mittelstaedt D, De La Vega DJ, Brumm D, Jolly DJ, Chang SMW. Sustained high level factor VIII expression in immunocompetent rabbits and dogs following peripheral intravenous injection of retroviral vector. Thromb Haemost (Suppl.) 1997, 3."},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0065","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1073\/pnas.96.18.10379","article-title":"Long term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in FVIII deficient mice","volume":"96","author":"VandenDriessche","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0070","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","article-title":"Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy","volume":"91","author":"Connelly","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2141.1999.01137.x","article-title":"Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to hemophilia A gene therapy","volume":"104","author":"Gnatenko","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0080","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1073\/pnas.96.22.12725","article-title":"Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein","volume":"96","author":"Burton","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0085","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599","article-title":"expression of human factor VIII in mice using a parvovirus-based vector","volume":"95","author":"Hengjum Chao Mao","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/10430340050015491","article-title":"Partial correction of murine hemophilia A with neo-antigenic murine factor VIII","volume":"11","author":"Sarkar","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng0797-270","article-title":"Persistent therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors","volume":"16","author":"Snyder","year":"1997","journal-title":"Nat Genet"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0100","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","article-title":"Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver","volume":"91","author":"Nakai","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/4743","article-title":"Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector","volume":"5","author":"Herzog","year":"1999","journal-title":"Nat Med"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/4751","article-title":"Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors","volume":"5","author":"Snyder","year":"1999","journal-title":"Nat Med"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0115","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/protein\/6.6.669","article-title":"Efficient production of recombinant human factor VIII by co-expression of the heavy and light chains","volume":"6","author":"Yonemura","year":"1993","journal-title":"Protein Engineering"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0130","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1128\/JVI.72.12.10222-10226.1998","article-title":"Adeno-associated virus as a vector for liver-directed gene therapy","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0135","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0140","first-page":"1","volume":"1","author":"Snyder","year":"1996"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V91.3.784","article-title":"Human FIX corrects the bleeding diathesis of mice with hemophilia B","volume":"91","author":"Kung","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0150","first-page":"1026","article-title":"Kinetic analysis PCR. Real-time monitoring of DNA amplification reaction","volume":"11","author":"Higuchi","year":"1993","journal-title":"Biotechnology"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/gr.4.6.357","article-title":"Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization","volume":"4","author":"Livak","year":"1995","journal-title":"PCR Methods Applications"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0160","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in-vivo functional characterization of B-domain deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0165","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","article-title":"Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy","volume":"97","author":"Yan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/6429","article-title":"Gene therapy and the germline","volume":"5","year":"1999","journal-title":"Nat Med"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0175","first-page":"802","article-title":"Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer","volume":"3","author":"Guo","year":"1996","journal-title":"Gene Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0180","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.75.16.7662-7671.2001","article-title":"Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differntiation","volume":"75","author":"Duan","year":"2001","journal-title":"J Virol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mthe.2000.0219","article-title":"Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors","volume":"2","author":"Chao","year":"2000","journal-title":"Mol Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0190","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J Virol"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0195","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/S0021-9258(18)68793-9","article-title":"Synthesis, processing and secretion of recombinant human factor VIII expressed in mammalian cells","volume":"263","author":"Kaufman","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0200","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1089\/10430340050111359","article-title":"Direct exposure of mouse spermatogenic cells to high doses of adenovirus gene therapy vector does not result in germ cell transduction","volume":"11","author":"Hall","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0205","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/mthe.2001.0491","article-title":"Lack of germline transmission of vector sequences following systematic administration of recombinant AAV02 vector in males","volume":"4","author":"Arruda","year":"2001","journal-title":"Mol Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0210","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/hum.1998.9.14-2135","article-title":"Evaluating the potential of germline transmission after intravenous administration of recombinant adenovirus in the C3H mouse","volume":"9","author":"Ye","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/mthe.2001.0500","article-title":"Absence of germline infection in male mice following intraventricular injection of adenovirus","volume":"4","author":"Peters","year":"2001","journal-title":"Mol Ther"},{"key":"10.1046\/j.1538-7836.2003.00096.x_bb0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/9638","article-title":"Endogenous insertional mutations in the human germline","volume":"22","author":"Kazazian","year":"1999","journal-title":"Nat Genet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622147173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622147173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1538-7836.2003.00096.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:23:49Z","timestamp":1761531829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622147173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S1538783622147173"],"URL":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00096.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00096.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}